ELAN - Elanco Animal Health Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.67
DETAILS
HIGH:
$30.00
LOW:
$23.00
MEDIAN:
$30.00
CONSENSUS:
$28.67
UPSIDE:
31.94%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 43.5% |
| EBIT Margin | -0.1% |
| EBITDA Margin | 14.3% |
| Operating Margin | 5.3% |
| Pretax Margin | -4.8% |
| Cont. Ops Margin | -4.9% |
| Net Margin | -4.9% |
| Bottom Line Margin | -4.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 2.17 |
| Quick Ratio | 1.08 |
| Solvency Ratio | 0.066 |
| Cash Ratio | 0.34 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | 0.29 |
| Forward PEG | 0.29 |
| Price/Book | 1.72 |
| Price/Sales | 2.38 |
| Price/FCF | 39.55 |
| Price/Op Cash Flow | 20.06 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.3007 |
| Debt/Equity | 0.6136 |
| Debt/Capital | 0.3803 |
| Long-Term Debt/Capital | 0.3759 |
| Financial Leverage | 2.04 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 2.51 |
| Operating Cash Flow Ratio | 0.351 |
| Operating Cash Flow/Sales | 11.9% |
| Free Cash Flow/Operating Cash Flow | 50.7% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 2.27 |
| Interest Coverage | 1.1455 |
| Short-Term Operating Cash Flow Coverage | 7.57 |
| Operating Cash Flow Coverage | 0.14 |
| Capital Expenditure Coverage | 2.03 |
| Dividend + Capital Expenditure Coverage | 2.03 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 9.50 |
| EPS | -0.467 |
| Debt/Share | 8.5355 |
| Cash/Share | 1.10 |
| Book Value/Share | 13.19 |
| Tangible BV/Share | -3.30 |
| Equity/Share | 13.19 |
| Operating Cash Flow/Share | 1.128 |
| Capital Expenditure/Share | 0.556 |
| FCF/Share | 0.572 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.036 |
| Earnings Before Tax/EBIT | -0.889 |
| Price/Fair Value | 1.72 |
| Debt/Market Cap | 0.3576 |
| Effective Tax Rate | -3.6% |
| Enterprise Value Multiple | 21.75 |